With the first landmark penalty officially issued under the Digital Services Act, Very Large Online…
With the first landmark penalty officially issued under the Digital Services Act, Very Large Online…
Through our partnership with the Independent Beauty Association and our sponsorship of the Fiscal Note U.S. Policy Map, we equip beauty brands with real-time regulatory insights and expert support, helping them stay compliant with MoCRA and confidently navigate the U.S. market.
Obelis COO Doram Elkayam shares how he navigates complex EU, UK, US, Swiss and Canadian regulations to streamline multi-market access for medical devices, IVDs, cosmetics and more. In this interview, he reflects on 2025, key trends for 2026, and why smart regulatory strategy is now a business essential.
From 1 July 2025, the EU will enforce new limits on Homosalate in cosmetics, allowing a max of 7.34% in face products. Reformulation may be required to ensure compliance.
Discover Health Canada’s update requiring a Canadian-based representative for foreign cosmetic brands and how Obelis can help with compliance.
Dutch audits reveal non-compliance with EU post-market surveillance (PMS) requirements for medical devices. Learn how to strengthen PMS systems for compliance and safety.
Discover the new EU General Product Safety Regulation (GPSR) requirements effective 13 December 2024. Learn about the role of Responsible Person and Authorised Representative (EAR) to ensure product compliance in the EU market.
From 13 December 2024, the new EU General Product Safety Regulation (GPSR) applies, requiring stricter safety measures and a Responsible Person for all products.
The update aims to address shortcomings in protecting children from toy-related risks, notably concerning hazardous chemicals.
Find out the 2024 updates regarding Medical devices, In-Vitro diagnostics, cosmetics, construction products, toys and more!